Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Pharmaceutical Drug and API Import from Georgia to Russia

Tuesday, July 2, 2019

In 2018, Russia imported 774.4 mln RUB worth of pharmaceuticals, which is in monetary terms (rubles) 8.7% higher than that of 2017, and 23.1 mln rub worth of APIs, which is monetary terms nearly 44% higher than that of 2017. The dynamics for the first three months of 2019 are even more impressive, with a 3.1 times increase for ready-made pharmaceuticals and a 3 times increase for APIs. However, this is due to lower importing activity in 2017.

In 2018, Russia imported 27 trademarks of ready-made pharmaceuticals and 1 API from 2 Georgian pharmaceutical companies. Russia imported only one pharmaceutical drug, cardiotonic agent Adenocin from EGV Pharma, which accounts for only 0.5% of the total Georgian import volume in monetary terms. As for APIs, Russia imported only Platyphyllin Hydrotartrate by GFL (Georgian Phytolaboratory), the only imported of Platyphyllin to Russia.

Georgia-made products accounts for only 3.4% of the total Georgian pharmaceutical import to Russia in 2018 in monetary terms. The absolute leaders are Indian manufacturers; India-made products account for 46.4% of the Georgian pharmaceutical import to Russia. There are 4 Indian pharmaceutical manufacturers and 13 trademarks. Antiaggregant Pletaks (Cilostazol), registered for Russian company Esko Pharma and manufactured by Novalek Pharmaceuticals (India), is the leader in import volume, even though Russia began importing Pletaks as late as in 2018.

India is followed by Bulgarian and Romanian products (19.8% and 9.7%, respectively), with vasodilating agent Dusopharm (Naftidrofuryl) for Esko Pharma by Bulgaria and Methortrit (Methotrexate) by Rompharm (Romania).

Significant part of the import has also signs of parallel import, in particular, between 2017 and 2018 Russia imported relatively small volumes of Regulon and Curiosin (Gedeon Richter), Vitrum (Unipharm), Snup (Stada) and others. The signs of parallel imports are as follows: insignificant shade in the total import volume, different countries of consignment and sender companies, different Russian importers, different payments currencies and payer bank and so on.

Dynamics of pharmaceutical drug and API import volumes from Georgia to Russia (2016 – 2018, Q1 2019), free circulation prices, customs duties and VAT included